Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
SINTX Technologies Inc(SINT)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for SINT
10/08/2026: SINT (1-star) has a low Upturn Star Rating. Not recommended to BUY.
SINTX Technologies is a micro-cap company specializing in silicon nitride ceramics, a material with unique antimicrobial properties utilized in both medical devices and industrial components. While the company possesses proprietary technology and FDA-cleared products, it faces significant challenges, including persistent operating losses and heavy reliance on share dilution for funding. The investment story centers on the company's ability to successfully monetize its technology across diverse, high-growth industrial markets rather than relying solely on the competitive orthopedic sector. Investors must carefully monitor the company's cash burn and revenue growth from contract manufacturing. Given the high volatility and financial risk, this stock is better suited for speculative investors rather than those seeking stability or income.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Weak fit | The company has yet to demonstrate consistent, scalable revenue growth required for a classic growth investment. |
| Momentum investor | Mixed fit | The stock is highly volatile and speculative, often driven by news flow rather than long-term performance trends. |
| Value investor | Weak fit | Valuation is difficult to justify based on traditional metrics like P/E or cash flow due to ongoing losses. |
| Dividend investor | Weak fit | The company does not pay a dividend and requires capital for survival rather than returning cash to shareholders. |
| Low-risk investor | Weak fit | The company is a high-risk micro-cap entity with significant business and execution risks. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock is prone to sharp price swings, making it unsuitable for capital preservation goals. |
| Valuation risk | High | The absence of profitability makes valuation multiples highly speculative and potentially disconnected from fundamentals. |
| Competition risk (Medical Devices) | High | The company competes against massive, established firms with significantly larger R&D and distribution budgets. |
| Business quality | Medium | While the technology is innovative, the underlying business model has yet to achieve the scale required for stability. |
| Dividend income | Low / none | This is a growth-stage or speculative company not designed to provide income to investors. |
| Execution risk | High | The company must successfully transition its material science into mass-market industrial and medical applications. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -18.2% | Avg. Invested days 9 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/08/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 14.46M USD | Price to earnings Ratio - | 1Y Target Price 9.25 |
Price to earnings Ratio - | 1Y Target Price 9.25 | ||
Volume (30-day avg) 64.4K shares | Beta 0.59 | 52 Weeks Range 1.40 - 4.64 | Updated Date 10/07/2026 |
52 Weeks Range 1.40 - 4.64 | Updated Date 10/07/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -4.86 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Medical Devices | Sale of spinal fusion implants and related orthopedic hardware. | Revenue comes from selling high-tech, ceramic-based medical implants to hospitals and surgeons. |
| Contract Manufacturing | Producing specialized ceramic components for third-party industrial and aerospace clients. | The company uses its manufacturing facility to create custom ceramic parts for other companies. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE - | Forward PE - | Enterprise Value 11.42M | Price to Sales(TTM) 10.87 |
Enterprise Value 11.42M | Price to Sales(TTM) 10.87 | ||
Enterprise Value to Revenue 10.53 | Enterprise Value to EBITDA -0.56 | Shares Outstanding 6.66M | Shares Floating 5.48M |
Shares Outstanding 6.66M | Shares Floating 5.48M | ||
Percent Insiders 22.14 | Percent Institutions 14.55 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About SINTX Technologies Inc
Exchange NASDAQ | Headquarters Salt Lake City, UT, United States | ||
IPO Launch date 2014-02-13 | CEO & Chairman of the Board Mr. Eric K. Olson | ||
Sector Healthcare | Industry Medical Devices | Full time employees 32 | Website https://www.sintx.com |
Full time employees 32 | Website https://www.sintx.com | ||
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.